[Recurrent Eyelid Tumors with Different Dignities]

Overview

Journal Ophthalmologe

Specialty Ophthalmology

Date 2019 Jun 30

PMID 31254059

Citations 1

Authors

U Low

C S L Muller

E Zemova

F A Flockerzi

B Seitz

Affiliations

Soon will be listed here.

Citing Articles

[Hordeolum and chalazion : (Differential) diagnosis and treatment].

Loth C, Miller C, Haritoglou C, Messmer E Ophthalmologe. 2021; 119(1):97-108.

PMID: 34379160 DOI: 10.1007/s00347-021-01436-y.

References

Goldberg M, Rummelt C, Foja S, Holbach L, Ballhausen W . Different genetic pathways in the development of periocular sebaceous gland carcinomas in presumptive Muir-Torre syndrome patients. Hum Mutat. 2006; 27(2):155-62. DOI: 10.1002/humu.20281. View

South C, Hampel H, Comeras I, Westman J, Frankel W, de la Chapelle A . The frequency of Muir-Torre syndrome among Lynch syndrome families. J Natl Cancer Inst. 2008; 100(4):277-81. DOI: 10.1093/jnci/djm291. View

Cook Jr B, Bartley G . Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. Ophthalmology. 2001; 108(11):2088-98; quiz 2099-100, 2121. DOI: 10.1016/s0161-6420(01)00796-5. View

Cohen P, KOHN S, Kurzrock R . Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med. 1991; 90(5):606-13. View

Lynch H, Lynch P, Pester J, Fusaro R . The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre's syndrome. Arch Intern Med. 1981; 141(5):607-11. View

Cohen P, KOHN S, Davis D, Kurzrock R . Muir-Torre syndrome. Dermatol Clin. 1995; 13(1):79-89. View

Muqit M, Roberts F, Lee W, Kemp E . Improved survival rates in sebaceous carcinoma of the eyelid. Eye (Lond). 2004; 18(1):49-53. DOI: 10.1038/sj.eye.6700523. View

Muir E, Bell A, Barlow K . Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face. Br J Surg. 1967; 54(3):191-5. DOI: 10.1002/bjs.1800540309. View

Brown J . Multiple sebaceous gland tumours associated with polyposis of the colon and bony abnormalities. Can Med Assoc J. 1974; 110(12):1377-9. PMC: 1947634. View

10.

Bapat B, Xia L, Madlensky L, Mitri A, Tonin P, Narod S . The genetic basis of Muir-Torre syndrome includes the hMLH1 locus. Am J Hum Genet. 1996; 59(3):736-9. PMC: 1914892. View

11.

Paraf F, Sasseville D, Watters A, Narod S, Ginsburg O, Shibata H . Clinicopathological relevance of the association between gastrointestinal and sebaceous neoplasms: the Muir-Torre syndrome. Hum Pathol. 1995; 26(4):422-7. DOI: 10.1016/0046-8177(95)90144-2. View

12.

Akhtar S, Oza K, Khan S, Wright J . Muir-Torre syndrome: case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature. J Am Acad Dermatol. 1999; 41(5 Pt 1):681-6. DOI: 10.1016/s0190-9622(99)70001-0. View

13.

Graefe T, Wollina U, Schulz H, Burgdorf W . Muir-Torre syndrome - treatment with isotretinoin and interferon alpha-2a can prevent tumour development. Dermatology. 2000; 200(4):331-3. DOI: 10.1159/000018399. View

14.

Kass L, Hornblass A . Sebaceous carcinoma of the ocular adnexa. Surv Ophthalmol. 1989; 33(6):477-90. DOI: 10.1016/0039-6257(89)90049-0. View

15.

Ollila S, Fitzpatrick R, Sarantaus L, Kariola R, Ambus I, Velsher L . The importance of functional testing in the genetic assessment of Muir-Torre syndrome, a clinical subphenotype of HNPCC. Int J Oncol. 2005; 28(1):149-53. View

16.

Schwartz R, Torre D . The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol. 1995; 33(1):90-104. DOI: 10.1016/0190-9622(95)90017-9. View

17.

Holbach L, von Moller A, Decker C, Junemann A, Ballhausen W . Loss of fragile histidine triad (FHIT) expression and microsatellite instability in periocular sebaceous gland carcinoma in patients with Muir-Torre syndrome. Am J Ophthalmol. 2002; 134(1):147-8. DOI: 10.1016/s0002-9394(02)01434-4. View

18.

Kruse R, Rutten A, Lamberti C, Wang Y, Ruelfs C, Jungck M . Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet. 1998; 63(1):63-70. PMC: 1377247. DOI: 10.1086/301926. View

19.

Umar A, Boland C, Terdiman J, Syngal S, de la Chapelle A, Ruschoff J . Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004; 96(4):261-8. PMC: 2933058. DOI: 10.1093/jnci/djh034. View

20.

Hampel H, Peltomaki P . Hereditary colorectal cancer: risk assessment and management. Clin Genet. 2000; 58(2):89-97. DOI: 10.1034/j.1399-0004.2000.580201.x. View